Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2017 07:30 ET | Source: MacroGenics, Inc.

MacroGenics to Present at the 35th Annual J.P. Morgan Healthcare Conference

ROCKVILLE, MD, Jan. 05, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
December 13, 2016 12:30 ET | Source: MacroGenics, Inc.

MacroGenics Highlights Progress at 2016 R&D Day

Advancement of HER2 franchise led by margetuximabExpansion and progression of B7-H3 franchiseIntroduction of PD-1 directed immuno-oncology franchiseClinical updates on multiple DART® studies...
December 12, 2016 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Licenses Synthon’s Technology to Develop an Anti-B7-H3 ADC

ROCKVILLE, Md. and NIJMEGEN, the Netherlands, Dec. 12, 2016 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing...
December 08, 2016 09:15 ET | Source: MacroGenics, Inc.

MacroGenics to Host 2016 R&D Day

ROCKVILLE, MD, Dec. 08, 2016 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
November 02, 2016 16:01 ET | Source: MacroGenics, Inc.

MacroGenics Provides Update on Corporate Progress and Third Quarter 2016 Financial Results

Continued expansion and advancement of product candidatesPortfolio update planned for upcoming R&D Day on December 13, 2016 ROCKVILLE, Md., Nov. 02, 2016 (GLOBE NEWSWIRE) -- MacroGenics, Inc....
November 01, 2016 17:00 ET | Source: MacroGenics, Inc.

MacroGenics to Participate in Two Upcoming Investor Conferences

Rockville, MD, Nov. 01, 2016 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
October 26, 2016 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Date of Third Quarter 2016 Financial Results Conference Call

Rockville, MD, Oct. 26, 2016 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Wednesday, November 2, 2016, the Company will release its financial results for the...
September 23, 2016 07:30 ET | Source: MacroGenics, Inc.

MacroGenics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable

Rockville, MD, Sept. 23, 2016 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
September 20, 2016 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces the Promotion of Three Executives

Rockville, MD, Sept. 20, 2016 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
September 12, 2016 07:00 ET | Source: MacroGenics, Inc.

Takeda and MacroGenics Announce the Conclusion of their MGD010 License and Option Agreement

Rockville, MD, Sept. 12, 2016 (GLOBE NEWSWIRE) -- and Osaka, Japan, Sept. 12, 2016 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and...